We believe there exists an attractive investment opportunity yet to be recognized by the financial community at large – just as was seen in the early years of legal cannabis.
We believe we are at the start of a neurowellness and brain health megatrend. The time has come for people to take care of their mind in the same way they take care of their bodies.
By connecting with the right people and providing venture capital to early industry operators, Phyto helped grow the Cannabis industry from $4 billion in sales in 2015 to nearly $25 billion in 2021.
We have applied this same approach to our new psychedelic-focused fund, Phyto Psyche.
The burden of depressive symptoms has tripled since 2019.
31% of patients
have treatment-resistant depression.
1 of every 8 ER visits
are linked to mental health and substance abuse disorders
Less then half
of all U.S. adults with mental health illness received treatment in 2020
71% response rate
of Esketamine + antidepressant therapy demonstrated rapid antidepressant effects in treatment-resistant depression
70% response rate
of Ketamine infusions demonstrating rapid antidepressant effects in treatment-resistant depression
6 academic institutions
have opened dedicated psychedelic research centers
>$730 Million
was invested across 51 psychedelics transactions in 2021
“Phyto has been incredibly helpful in our
networking with new clients
and positioning us to scale to new
states.”
“All of us knew we needed experienced investors with their finger on the pulse of the Cannabis industry. Phyto brought exactly that.”
“Wesana has benefited tremendously from our relationship with Phyto. I personally value the personal relationship I have with the team and the market insights they provide.”
"Phyto have been true partners, lending their insights, facilitating partnerships, participating in co-marketing events and introductions to other strategic groups.”
“The powerful ally you want supporting your growth, the Phyto team delivers with strategic connections and advice when you need it.”
"Phyto has been instrumental in helping raise capital for Lucid Green and has helped with ongoing business development and partnerships.”
"PhytoPartners has been an incredible partner and resource for Willow. I am thrilled to be one of their portfolio companies and look forward to much success with them now and in the future.”
"The Phyto team has been instrumental in Heally’s growth and success in Cannabis telehealth expansion and Larry was early pointing us to the neurowellness opportunity.”